TY  - GEN
AB  - Attention has recently turned to using plants as hosts for the production of commercially important proteins. The twelve case studies in this volume present successful strategies for using plants to produce industrial and pharmaceutical proteins and vaccine antigens. They examine in detail projects that have commercial potential or products that have already been commercialized, illustrating the advantages that plants offer over bacterial, fungal or animal cell-culture hosts. There are many indications that plant protein production marks the beginning of a new paradigm for the commercial production of proteins that, over the next decade, will expand dramatically.
AU  - Howard, John A.,
AU  - Hood, Elizabeth E.,
CN  - TP248.27.P55
DO  - 10.1007/978-3-662-43836-7
DO  - doi
ID  - 760630
KW  - Plant proteins
KW  - Plant biotechnology.
LK  - https://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-662-43836-7
N1  - Includes index.
N2  - Attention has recently turned to using plants as hosts for the production of commercially important proteins. The twelve case studies in this volume present successful strategies for using plants to produce industrial and pharmaceutical proteins and vaccine antigens. They examine in detail projects that have commercial potential or products that have already been commercialized, illustrating the advantages that plants offer over bacterial, fungal or animal cell-culture hosts. There are many indications that plant protein production marks the beginning of a new paradigm for the commercial production of proteins that, over the next decade, will expand dramatically.
SN  - 9783662438367
SN  - 3662438364
T1  - Commercial plant-produced recombinant protein products :case studies /
TI  - Commercial plant-produced recombinant protein products :case studies /
UR  - https://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-662-43836-7
VL  - volume 68
ER  -